-+ 0.00%
-+ 0.00%
-+ 0.00%

TRAWS PHARMA - COMPANY TO INITIATE PROFILING OF ADDITIONAL MOLECULES FOR INFLUENZA TREATMENT PROGRAM

Reuters·06/22/2026 11:00:28

Please log in to view news